BioLargo Cash Flow - Quarterly (OTCMKTS:BLGO)

Add to My Stocks
$0.33 $0.01 (3.13%) BLGO stock closing price Jul 13, 2018 (Closing)

The BioLargo cash flow statement is one of the important reports considered by investors doing a fundamental analysis of the company. In simple terms, the cash flow statement measures the cash that has come into the company, and the cash that has gone out during a given period, while the other statements, the income statement and balance sheet, give details about BioLargo profits and BioLargo debt. Items like capital purchases, bank loan payments etc. which have a direct impact on the cash position of a company come out through the statemement of cash flows and help an investor who undertakes the BioLargo stock analysis. BioLargo generated $-0.99M cash from operating activities in till this quarter of 2018 Q1. BioLargo had an outflow of $-0.99M from operating activities, $- spend due to financing activities, and $-0.01M outflow due to investing activities till 2018 Q1.

View and download details of BioLargo cash flows for latest & last 40 quarters
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow---1.73M------
Net Increase (Decrease) in Assets Liabilities--0.03M---0.18M-0.18M-0.13M-0.03M-0.11M-0.12M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net1.32M5.27M3.88M-1.06M4.52M3.12M--3.31M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.01M-0.02M-0.01M---0.06M-0.05M-0.01M--
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments----------
Other Cash Inflow (Outflow) from Investment Activities----------
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares-1.37M-------3.55M
Issuance (Repayment) of Debt Securities----------
Increase (Decrease) in Bank & Other Borrowings-1.99M1.51M--3.1M2.19M---
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities----------0.02M
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash----0.01M-0.01M-0.04M-0.02M-0.01M-0.01M-0.04M
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year1.91M1.76M--------
Cash & Equivalents at Year End--1.25M-1.17M1.91M1.73M-1.02M1.76M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

While BioLargo stock price history provides the price history of a stock, BioLargo stock comparison chart shows the same in comparison to peers, and cash flow statements provide cash position of the company. Common terms used in the statement of cash flows are:

  • Net Change in Cash and Cash Equivalents: A positive net change in cash and cash equivalents shows that BioLargo is able to meet its expenditure and grow cash at hand which demonstrates the financial strength of the company's balance sheet. Also see - BioLargo stock price movement.
  • Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. BioLargo lost $-0.99M cash from operations. It is important to check this to see where the company is getting its money from.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $-0.01M for BLGO till last quarter 2018 Q1 report.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $- for BioLargo.

Key Financial Ratios For BioLargo Cash Flow